Collegium Pharmaceutical Inc (NAS:COLL)
$ 31.68 0.1 (0.32%) Market Cap: 1.04 Bil Enterprise Value: 1.35 Bil PE Ratio: 13.15 PB Ratio: 4.66 GF Score: 73/100

Collegium Pharmaceutical Inc To Acquire BioDelivery Sciences International Inc - M&A Call Transcript

Feb 14, 2022 / 01:30PM GMT
Release Date Price: $19.9 (+13.13%)
Operator

Hello, and welcome to the Collegium Pharmaceutical Investor Update Conference Call and Webcast. (Operator Instructions)

As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Alex Dasalla, Head of Investor Relations and Corporate Communications. Please go ahead.

Alex Dasalla
Collegium Pharmaceutical, Inc. - Head of IR

Thank you, operator. This is Alex Dasalla, Head of Investor Relations and Corporate Communications at Collegium Pharmaceutical. I'd like to welcome you all this morning to our investor call to discuss Collegium's acquisition of BioDelivery Sciences International, known as BDSI, which we announced jointly in a press release issued earlier today.

Joining me on the call are Joe Ciaffoni, our Chief Executive Officer; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer. Joe and Colleen will share some prepared remarks, and then we will take your questions.

Please note that in addition to the aforementioned press release, Collegium has been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot